NO2776955T3 - - Google Patents
Info
- Publication number
- NO2776955T3 NO2776955T3 NO12848689A NO12848689A NO2776955T3 NO 2776955 T3 NO2776955 T3 NO 2776955T3 NO 12848689 A NO12848689 A NO 12848689A NO 12848689 A NO12848689 A NO 12848689A NO 2776955 T3 NO2776955 T3 NO 2776955T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161528893P | 2011-08-30 | 2011-08-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2776955T3 true NO2776955T3 (hr) | 2018-06-02 |
Family
ID=46829875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO12848689A NO2776955T3 (hr) | 2011-08-30 | 2012-11-09 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9512140B2 (hr) |
| EP (1) | EP2751115B1 (hr) |
| JP (1) | JP6042436B2 (hr) |
| KR (1) | KR101596607B1 (hr) |
| CN (1) | CN103958523B (hr) |
| AU (1) | AU2012300451B2 (hr) |
| BR (1) | BR112014004557A2 (hr) |
| CA (1) | CA2843514C (hr) |
| DK (1) | DK2751115T3 (hr) |
| EA (1) | EA024248B1 (hr) |
| ES (1) | ES2650225T3 (hr) |
| HR (1) | HRP20171824T1 (hr) |
| HU (1) | HUE034845T2 (hr) |
| LT (1) | LT2751115T (hr) |
| MX (1) | MX350419B (hr) |
| NO (1) | NO2776955T3 (hr) |
| PL (1) | PL2751115T3 (hr) |
| PT (1) | PT2751115T (hr) |
| RS (1) | RS56537B1 (hr) |
| SI (1) | SI2751115T1 (hr) |
| WO (1) | WO2013032804A1 (hr) |
| ZA (1) | ZA201400874B (hr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012283035B2 (en) * | 2011-07-08 | 2015-07-30 | Eli Lilly & Company | (thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists |
| PL2943498T3 (pl) | 2013-01-14 | 2018-01-31 | Lilly Co Eli | Związki (tieno[2,3-b][1,5]benzoksazepin-4-ylo)piperazyn-1-ylowe jako odwrotni agoniści h1 / antagoniści 5-ht2a o podwójnej aktywności |
| TW201625644A (zh) | 2014-04-29 | 2016-07-16 | 美國禮來大藥廠 | 作為選擇性５－ＨＴＡ反向促效劑之（噻吩并［２，３－ｂ］［１，５］苯并氧氮呯－４－基）哌嗪－１－基化合物 |
| WO2018177993A1 (de) | 2017-03-31 | 2018-10-04 | Bayer Cropscience Aktiengesellschaft | Pyrazole zur bekämpfung von arthropoden |
| WO2018234488A1 (en) | 2017-06-23 | 2018-12-27 | Basf Se | Substituted cyclopropyl derivatives |
| WO2019185413A1 (en) | 2018-03-27 | 2019-10-03 | Basf Se | Pesticidal substituted cyclopropyl derivatives |
| PL3898602T3 (pl) | 2018-12-21 | 2023-10-23 | Ogeda N.V. | Synteza 3-metylo-1,2,4-tiadiazolo-5-karbohydrazydu lub jego metylo-d3 deuterowanej postaci |
| MX2022004736A (es) * | 2019-10-21 | 2022-07-27 | Alairion Inc | Derivados de acido 3-(4-(11h-dibenzo [b, e] [1, 4] azepin-6-il)piperazin-1-il)- y 3-(4- dibenzo [b, f] [1, 4] oxazepin/tiazepin/diazepin-11-il)piperazin-1-il)propanoico como moduladores de los receptores h1 y 5-ht2a para el tratamiento de los trastornos del sue?o. |
| EP4043444A1 (en) | 2021-02-11 | 2022-08-17 | Basf Se | Substituted isoxazoline derivatives |
| IL304983A (en) | 2021-02-11 | 2023-10-01 | Basf Se | Isoxazoline histories are transmuted |
| WO2024089216A1 (en) | 2022-10-27 | 2024-05-02 | Syngenta Crop Protection Ag | Novel sulfur-containing heteroaryl carboxamide compounds |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7395251B2 (en) * | 2005-07-01 | 2008-07-01 | International Business Machines Corporation | Neural networks for prediction and control |
| US7807828B2 (en) * | 2005-08-11 | 2010-10-05 | Hypnion, Inc. | Olanzapine analogs and methods of use thereof |
-
2012
- 2012-08-22 SI SI201231078T patent/SI2751115T1/sl unknown
- 2012-08-22 KR KR1020147004807A patent/KR101596607B1/ko not_active Expired - Fee Related
- 2012-08-22 EP EP12756856.6A patent/EP2751115B1/en active Active
- 2012-08-22 RS RS20171126A patent/RS56537B1/sr unknown
- 2012-08-22 JP JP2014528453A patent/JP6042436B2/ja not_active Expired - Fee Related
- 2012-08-22 PT PT127568566T patent/PT2751115T/pt unknown
- 2012-08-22 BR BR112014004557A patent/BR112014004557A2/pt not_active IP Right Cessation
- 2012-08-22 US US14/131,695 patent/US9512140B2/en not_active Expired - Fee Related
- 2012-08-22 HR HRP20171824TT patent/HRP20171824T1/hr unknown
- 2012-08-22 PL PL12756856T patent/PL2751115T3/pl unknown
- 2012-08-22 ES ES12756856.6T patent/ES2650225T3/es active Active
- 2012-08-22 DK DK12756856.6T patent/DK2751115T3/en active
- 2012-08-22 HU HUE12756856A patent/HUE034845T2/en unknown
- 2012-08-22 LT LTEP12756856.6T patent/LT2751115T/lt unknown
- 2012-08-22 AU AU2012300451A patent/AU2012300451B2/en not_active Ceased
- 2012-08-22 WO PCT/US2012/051833 patent/WO2013032804A1/en not_active Ceased
- 2012-08-22 EA EA201490332A patent/EA024248B1/ru not_active IP Right Cessation
- 2012-08-22 CN CN201280040793.9A patent/CN103958523B/zh not_active Expired - Fee Related
- 2012-08-22 CA CA2843514A patent/CA2843514C/en not_active Expired - Fee Related
- 2012-08-22 MX MX2014002473A patent/MX350419B/es active IP Right Grant
- 2012-11-09 NO NO12848689A patent/NO2776955T3/no unknown
-
2014
- 2014-02-05 ZA ZA2014/00874A patent/ZA201400874B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA024248B1 (ru) | 2016-08-31 |
| RS56537B1 (sr) | 2018-02-28 |
| BR112014004557A2 (pt) | 2017-05-30 |
| DK2751115T3 (en) | 2017-10-23 |
| US20140171411A1 (en) | 2014-06-19 |
| EP2751115A1 (en) | 2014-07-09 |
| CN103958523B (zh) | 2016-07-27 |
| HUE034845T2 (en) | 2018-03-28 |
| AU2012300451B2 (en) | 2016-10-13 |
| SI2751115T1 (sl) | 2017-11-30 |
| EP2751115B1 (en) | 2017-09-20 |
| JP2014525440A (ja) | 2014-09-29 |
| MX2014002473A (es) | 2016-09-26 |
| JP6042436B2 (ja) | 2016-12-14 |
| CN103958523A (zh) | 2014-07-30 |
| MX350419B (es) | 2017-09-05 |
| WO2013032804A1 (en) | 2013-03-07 |
| CA2843514C (en) | 2017-01-10 |
| ES2650225T3 (es) | 2018-01-17 |
| LT2751115T (lt) | 2017-12-27 |
| AU2012300451A1 (en) | 2014-01-30 |
| PT2751115T (pt) | 2017-12-20 |
| KR20140051355A (ko) | 2014-04-30 |
| ZA201400874B (en) | 2015-10-28 |
| CA2843514A1 (en) | 2013-03-07 |
| EA201490332A1 (ru) | 2014-06-30 |
| KR101596607B1 (ko) | 2016-02-22 |
| HRP20171824T1 (hr) | 2017-12-29 |
| PL2751115T3 (pl) | 2018-02-28 |
| US9512140B2 (en) | 2016-12-06 |